SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001654954-20-000675
Filing Date
2020-01-23
Accepted
2020-01-22 19:08:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A edsa_13da.htm SC 13D/A 233631
  Complete submission text file 0001654954-20-000675.txt   235154
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Subject) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-87615 | Film No.: 20539962
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EDESA BIOTECH INC. 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address C/O EDESA BIOTECH INC. 100 SPY COURT MARKHAM A6 L3R 5H6 (905)475-1234
10379085 Canada Inc. (Filed by) CIK: 0001779970 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A